Retraction
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
Paper Information
Record ID:
33259
Author(s):
Journal:
Publication Date:
April 23, 2021
Retraction Date:
August 31, 2021
(4.2 years years ago)
Subjects:
Institutions:
- Center for Outcomes Research, Houston Methodist, Houston, TX
- Yale School of Medicine, Department of Medicine, Section of Infectious Diseases, New Haven, CT
- Department of Nuclear Engineering, Texas A&M University, College Station, TX
- Houston Methodist Academic Institute, Houston Methodist, Houston, TX
- Weill Cornell Medicine, Weill Cornell, New York, NY
- Yale School of Public Health, New Haven, CT
- Yale Institute of Global Health, New Haven, CT
- Yale School of Nursing, Orange, CT
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Cold Spring Harbor Laboratory Press
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (20)
20
Total Citations9
Post-Retraction(45.0%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
3
Within 30 days
9
Within 1 year
0
After 2+ years
224
Days since retraction (latest)
Explain Again: Why Are We Vaccinating Young Children against COVID-19?
Ray K. Iles, Tarek Sultani Makhzoumi
COVID
Open Access
Published: Apr 2022
2 citations
2 citations
224 days after retraction
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
Mohammad Mihrab Chowdhury, Md Rafiul Islam, Md Sakhawat Hossain et al. (5 authors)
Infectious Disease Modelling
Open Access
Published: Mar 2022
5 citations
5 citations
192 days after retraction
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
Chiara Ronchini, Sara Gandini, Sebastiano Pasqualato et al. (14 authors)
PLoS ONE
Open Access
Published: Jan 2022
21 citations
21 citations
153 days after retraction
Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries
John D Clemens, Asma Binte Aziz, Birkneh Tilahun Tadesse et al. (6 authors)
EClinicalMedicine
Open Access
Published: Dec 2021
18 citations
18 citations
115 days after retraction
Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021
Chang-Jie Cheng, Chun‐Yi Lu, Ya‐Hui Chang et al. (10 authors)
Vaccines
Open Access
Published: Dec 2021
21 citations
21 citations
107 days after retraction
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
Mohammad Mihrab Chowdhury, Md Rafiul Islam, Md Sakhawat Hossain et al. (5 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2021
1 citation
1 citation
90 days after retraction
Lower probability and shorter duration of infections after Covid-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
Chiara Ronchini, Sara Gandini, Sebastiano Pasqualato et al. (14 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2021
27 days after retraction
Positivity rate: an indicator for the spread of COVID-19
Ahmed Al Dallal, Usama AlDallal, Jehad Al Dallal
Current Medical Research and Opinion
Published: Sep 2021
20 citations
20 citations
14 days after retraction
SARS-CoV-2 infections in 165 countries over time
Stilianos Louca
International Journal of Infectious Diseases
Open Access
Published: Sep 2021
9 citations
9 citations
3 days after retraction
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada
Sara Carazo, Denis Talbot, Nicole Boulianne et al. (16 authors)
Clinical Infectious Diseases
Open Access
Published: Aug 2021
32 citations
32 citations
1 days before retraction
Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021
Chang-Jie Cheng, Chun‐Yi Lu, Ya‐Hui Chang et al. (10 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2021
6 citations
6 citations
3 days before retraction
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Alicia Sotomayor-González, Amelia S. Gliwa et al. (25 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2021
8 citations
8 citations
6 days before retraction
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham et al. (4 authors)
Immunity
Open Access
Published: Aug 2021
244 citations
244 citations
30 days before retraction
Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
Sara Carazo, Denis Talbot, Nicole Boulianne et al. (16 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
12 citations
12 citations
40 days before retraction
Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study
Maylis Layan, Mayan Gilboa, Tal Gonen et al. (9 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
28 citations
28 citations
46 days before retraction
Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
Charlotte Bermingham, Jasper Morgan, Daniel Ayoubkhani et al. (9 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
3 citations
3 citations
46 days before retraction
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Ottavia Prunas, Joshua L. Warren, Forrest W. Crawford et al. (7 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
47 citations
47 citations
46 days before retraction
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically ill – An interim analysis of a nationwide cohort study
Ulrike Baum, Eero Poukka, Arto A. Palmu et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2021
9 citations
9 citations
64 days before retraction
Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort Study
Katia Bruxvoort, Lina S. Sy, Lei Qian et al. (12 authors)
SSRN Electronic Journal
Published: Jan 2021
30 citations
30 citations
242 days before retraction
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines Against Symptomatic SARS-CoV-2 Infection and Severe COVID-19 Outcomes in Ontario, Canada
Hannah Chung, Siyi He, Sharifa Nasreen et al. (23 authors)
SSRN Electronic Journal
Open Access
Published: Jan 2021
31 citations
31 citations
242 days before retraction
Quick Stats
Total Citations:
20
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025